Qiang Hua
Direktor/Vorstandsmitglied bei ZHONGSHAN PUBLIC UTILITIES GROUP CO.,LTD
Aktive Positionen von Qiang Hua
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ZHONGSHAN PUBLIC UTILITIES GROUP CO.,LTD | Direktor/Vorstandsmitglied | 11.06.2020 | - |
| Independent Dir/Board Member | 11.06.2020 | - | |
NKD Pharma Co., Ltd.
 NKD Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology NKD Pharma Co., Ltd. engages in the provision of entrusted research and development services, and independent project research and development services. Its entrusted research and development services cover pharmaceutical research, non-clinical research, and clinical research services for pharmaceutical companies and pharmaceutical research and development investment companies. Its independent project research and development services encompass generic drug, medical devices, and special medical food development services. The company was founded by Peng Chen, Xiu Mei Tao, Chun Peng Wang, and Ke Min Li on July 23, 2013 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | 01.07.2018 | - |
| Independent Dir/Board Member | 01.07.2018 | - |
Karriereverlauf von Qiang Hua
Statistik
International
| China | 3 |
Operativ
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
Sektoral
| Health Technology | 2 |
| Utilities | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ZHONGSHAN PUBLIC UTILITIES GROUP CO.,LTD | Utilities |
| Private Unternehmen | 1 |
|---|---|
NKD Pharma Co., Ltd.
NKD Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology NKD Pharma Co., Ltd. engages in the provision of entrusted research and development services, and independent project research and development services. Its entrusted research and development services cover pharmaceutical research, non-clinical research, and clinical research services for pharmaceutical companies and pharmaceutical research and development investment companies. Its independent project research and development services encompass generic drug, medical devices, and special medical food development services. The company was founded by Peng Chen, Xiu Mei Tao, Chun Peng Wang, and Ke Min Li on July 23, 2013 and is headquartered in Beijing, China. | Health Technology |
